Education
About Us
Working with TipRanks
Follow Us
Opko Health (OPK)
:OPK
OPK Stock Chart & Stats
$1.53
-$0.03(-1.99%)
At close: 4:00 PM EST
$1.53
-$0.03(-1.99%)
Day’s Range― - ―
52-Week Range$1.11 - $2.04
Previous CloseN/A
Volume574.71K
Average Volume (3M)2.18M
Market Cap
$1.06B
Enterprise ValueN/A
Total Cash (Recent Filing)$415.20M
Total Debt (Recent Filing)$395.42M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Feb 19, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding767,701,300
10 Day Avg. Volume1,466,492
30 Day Avg. Volume2,176,778
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)0.75
Price to Sales (P/S)1.43
P/FCF Ratio-4.89
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$2.75Price Target Upside79.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash InfusionThe cash infusion from the sale provided resources for OPK to focus on its pipeline work.
Partnership OpportunitiesPartnered EBV opportunity through MDX2201 could be attractive, as EBV immunization could potentially reduce the risk of mononucleosis, multiple sclerosis, and certain cancer types.
ProfitabilityReaching profitability will not only provide a self-sustainable path for an important value driver at OPK, it will also offset the development costs that OPK will need to pursue its therapeutic goals.
Bears Say
Growth ChallengesOPK has been downgraded to a 'Hold' rating due to challenges in growth under the current status quo.
Pipeline ValidationThe broader clinical-stage pipeline portfolio remains early stage and needs clinical validation before we see buy-in from investors.
Revenue ShortfallTotal revenue of $151.7 million fell short of the consensus estimate of $160.8 million.
Opko Health News
OPK FAQ
What was Opko Health’s price range in the past 12 months?
Opko Health lowest stock price was $1.11 and its highest was $2.04 in the past 12 months.
What is Opko Health’s market cap?
Opko Health’s market cap is $1.06B.
When is Opko Health’s upcoming earnings report date?
Opko Health’s upcoming earnings report date is Feb 19, 2026 which is in 65 days.
How were Opko Health’s earnings last quarter?
Opko Health released its earnings results on Oct 29, 2025. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of -$0.06 by $0.09.
Is Opko Health overvalued?
According to Wall Street analysts Opko Health’s price is currently Undervalued.
Does Opko Health pay dividends?
Opko Health does not currently pay dividends.
What is Opko Health’s EPS estimate?
Opko Health’s EPS estimate is -0.07.
How many shares outstanding does Opko Health have?
Opko Health has 767,701,300 shares outstanding.
What happened to Opko Health’s price movement after its last earnings report?
Opko Health reported an EPS of $0.03 in its last earnings report, beating expectations of -$0.06. Following the earnings report the stock price went up 2.098%.
Which hedge fund is a major shareholder of Opko Health?
Currently, no hedge funds are holding shares in OPK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Opko Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.75 (79.74% Upside)
$2.75 (79.74% Upside)
Blogger Sentiment
Bullish
OPK Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 6.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $891.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.3%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.00%
12-Months-Change
Fundamentals
Return on Equity
-13.32%
Trailing 12-Months
Asset Growth
-0.35%
Trailing 12-Months
Company Description
Opko Health
Opko Health, Inc. is a diversified healthcare company focused on developing and commercializing innovative health solutions. The company operates primarily in the pharmaceuticals and diagnostics sectors, offering a range of products including proprietary pharmaceuticals, diagnostic products, and novel drug delivery systems. Opko Health is known for its commitment to advancing medical technology and improving patient outcomes through its core products such as the 4Kscore Test, a diagnostic test for prostate cancer, and a portfolio of pharmaceutical products that address various medical needs.
OPK Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects strong strategic moves such as the sale of non-core assets and significant partnerships, contributing to financial improvements and shareholder value. However, there are challenges in diagnostics revenue decline and slower-than-expected market conversion affecting Pfizer profit share.View all OPK earnings summariesOPK Stock 12 Month Forecast
Average Price Target
$2.75
▲(79.74% Upside)
Technical Analysis
Ownership Overview
46.12% Insiders
6.49% Mutual Funds
8.53% Other Institutional Investors
28.44% Public Companies and
Individual Investors